Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Journal of Toxicologic Pathology|October 30, 2014
Histological characteristics of the regression of corpora lutea in wistar hannover rats: the comparisons with sprague-dawley ratsJunko Sato, Satomi Hashimoto, Takuya Doi, et al.Journal of Toxicologic Pathology|October 25, 2013
Corneal mineralization in wistar hannover ratsSatomi Hashimoto, Takuya Doi, Yumi Wako, et al.Human Vaccines & Immunotherapeutics|December 15, 2016
Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosisMasaji Okada, Yoko Kita, Satomi Hashimoto, et al.Plant Molecular Biology|October 20, 2020
Genes encoding lipid II flippase MurJ and peptidoglycan hydrolases are required for chloroplast division in the moss Physcomitrella patensHanae Utsunomiya, Nozomi Saiki, Hayato Kadoguchi, et al.Journal of Toxicologic Pathology|October 25, 2013
Bacterial pleuritis with thickened mesothelial hyperplasia in a young beagle dogNaoaki Yamada, Satomi Hashimoto, Yuki Tomonari, et al.Journal of Toxicologic Pathology|January 25, 2012
Malignant Mesothelioma in the Thoracic Cavity of a Crj:CD(SD) Rat Characterized by Round Hyalinous StromaTakuya Doi, Yuri Kotani, Kazuaki Takahashi, et al.Clinical & Developmental Immunology|May 24, 2011
Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in miceMasaji Okada, Yoko Kita, Noriko Kanamaru, et al.Vaccine|October 12, 2005
DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activationShigeto Yoshida, Takao Tanaka, Yoko Kita, et al.Journal of Gastroenterology and Hepatology|September 20, 2012
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1bMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2014
Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral loadMasanori Atsukawa, Akihito Tsubota, Noritomo Shimada, et al.Pageof 3